Boston University Identifies Cardiovascular Metabolic Risk Patterns in Non-Diabetic Adults via CGM Data

September 20, 2026

EurekAlert! (Boston University Chobanian & Avedisian School of Medicine) USA

Overview

Researchers at Boston University have discovered that glucose patterns recorded by continuous glucose monitoring (CGM) devices in non-diabetic adults are significantly associated with markers of cardiometabolic risk. Specifically, higher average glucose levels and prolonged periods with glucose exceeding 140 mg/dL were linked to elevated blood pressure and cholesterol levels. This finding suggests that CGM could transform current clinical practice for cardiovascular disease risk stratification in non-diabetic individuals, extending its utility beyond diabetes management.

In Depth

Key Findings

Researchers at the Boston University Chobanian & Avedisian School of Medicine have made a significant discovery, demonstrating that continuous glucose monitoring (CGM) patterns in non-diabetic adults correlate strongly with established markers of cardiometabolic risk. This groundbreaking insight suggests a paradigm shift in how CGM technology could be utilized, moving beyond primary diabetes management to include proactive cardiovascular disease risk stratification in the general population.

Technical / Clinical Details

Study Cohort and Methodology: The study involved a large cohort of adults without a diabetes diagnosis, who wore CGM devices to track their glucose fluctuations continuously over an extended period. This methodology allowed for the detailed capture of glycemic responses to daily activities and dietary intake.
Key Associations Identified: The analysis revealed critical correlations between specific glucose patterns and cardiometabolic risk factors:
- Elevated Mean Glucose: Consistently higher average glucose levels over time were found to be associated with an increased risk of cardiovascular disease.
- Prolonged Hyperglycemia: Extended durations where blood glucose levels surpassed 140 mg/dL (7.8 mmol/L), indicative of frequent or sustained glucose spikes, were significantly correlated with higher prevalence of hypertension and elevated cholesterol levels.
Risk Markers Assessed: The research evaluated conventional cardiometabolic risk markers, including blood pressure readings, LDL and HDL cholesterol levels, and triglyceride concentrations.

Background & Context

While CGM has traditionally been a cornerstone tool for diabetes management, there’s growing interest in understanding the significance of glucose variability in pre-diabetic and healthy individuals. Postprandial hyperglycemia and frequent glucose spikes are increasingly recognized as contributing factors to pathophysiological changes that precede cardiovascular disease, such as insulin resistance, endothelial dysfunction, and chronic inflammation. This study is pivotal as it empirically validates CGM data as a powerful, non-invasive means to capture these subtle yet crucial indicators continuously.

Strategic Significance & Outlook

These findings hold the potential to redefine the role of CGM technology in general health management. In the future, CGM data could be integrated into routine health screenings to identify individuals at elevated risk for cardiovascular disease and type 2 diabetes much earlier. This would facilitate timely lifestyle modifications and preventive interventions, thereby advancing personalized preventive medicine and significantly improving public health outcomes. Clinicians and individuals alike could leverage a deeper understanding of glucose patterns to formulate concrete action plans aimed at mitigating long-term health risks.

Source: https://www.eurekalert.org/news-releases/1144090

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.